Stock & Company Details
Aprea Therapeutics Inc $APRE
Price:
N/A
N/A
14M
$7M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.46
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
APRE technical indicators
Latest Aprea Therapeutics Inc (APRE) indicator readings as of 2026-11-19.
APRE's 14-day RSI is 46.8, in neutral territory. ADX reads 32.5, indicating a trending market. MACD (12, 26, 9) is -0.04, below the zero line.
Overview
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).
Finance Bot
Ask your questions
Start by typing a question below.